Cargando…
Recent advances in understanding and managing epidermolysis bullosa
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous skin fragility disorder characterized by trauma-induced skin dissociation and the development of painful wounds. So far, mutations in 20 genes have been described as being associated with more than 30 clinical EB subtypes. The...
Autores principales: | Kiritsi, Dimitra, Nyström, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051194/ https://www.ncbi.nlm.nih.gov/pubmed/30057747 http://dx.doi.org/10.12688/f1000research.14974.1 |
Ejemplares similares
-
Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers
por: Nyström, Alexander, et al.
Publicado: (2021) -
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
por: Nyström, Alexander, et al.
Publicado: (2015) -
Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita
por: Schauer, Franziska, et al.
Publicado: (2022) -
Mechanism of Oleogel‐S10: A triterpene preparation for the treatment of epidermolysis bullosa
por: Schwieger‐Briel, Agnes, et al.
Publicado: (2019) -
Advances in understanding and treating dystrophic epidermolysis bullosa
por: Vanden Oever, Michael J, et al.
Publicado: (2014)